Standard BioTools Inc. (LAB) Income Annual - Discounting Cash Flows
LAB
Standard BioTools Inc.
LAB (NASDAQ)
Period Ending: LTM
(Last Twelve Months)
2024
12-31
2023
12-31
2022
12-31
2021
12-31
2020
12-31
2019
12-31
2018
12-31
2017
12-31
2016
12-31
2015
12-31
2014
12-31
2013
12-31
2012
12-31
2011
12-31
2010
12-31
2009
12-31
2008
12-31
2007
12-31
2006
12-31
Report Filing 2025-11-04 2025-03-11 2024-03-01 2023-03-14 2022-03-08 2021-02-25 2020-02-27 2019-03-18 2018-03-08 2017-04-28 2016-02-29 2015-02-26 2014-03-12 2013-03-12 2012-03-26 2011-03-28 2009-12-31 2008-12-31 2007-12-31 2006-12-31
Revenue 128.8 174.4 106.3 97.95 130.6 138.1 117.2 113 101.9 104.4 114.7 116.5 71.18 52.33 42.87 33.56 25.41 15.35 7.28 6.4
Cost of Revenue 67.07 90.17 55.89 60.9 61.21 54.82 52.96 51.31 49.95 46.01 46.63 42.85 20.08 15.32 13.19 11.58 11.49 8.36 3.51 2.77
Gross Profit 61.76 84.26 50.45 37.05 69.37 83.33 64.28 61.65 51.98 58.44 68.08 73.61 51.1 37.01 29.67 21.98 13.93 6.98 3.76 3.62
Operating Expenses 176.7 259.5 127 153.3 136.8 134.4 116.1 109.8 110.3 131.6 118.2 125.4 69.05 55.08 48.24 36.55 31.96 36.53 27.29 25.29
Research & Development 37.96 62.41 25.95 37.38 37.94 36.46 31.64 30.03 30.83 38.41 39.26 43.42 19.73 16.6 13.94 13.01 12.31 14.02 14.39 15.59
Selling, General and Administrative 131 156.6 87.54 102.3 98.89 97.9 84.48 79.78 79.52 93.21 82.96 71.32 48.05 38.48 31.3 23.55 19.65 22.51 12.9 9.7
Other Operating Expenses 7.75 40.48 13.56 13.59 0 0 0 0 0 0 -3.99 10.7 1.27 0 3 0 0 0 0 0
Operating Income -115 -175.2 -76.6 -116.2 -67.46 -51.04 -51.84 -48.16 -58.36 -73.19 -50.16 -51.84 -17.95 -18.07 -18.57 -14.57 -18.04 -29.54 -23.53 -21.66
Net Non-Operating Interest 7.5 16.88 1 -2.1 -3.82 -3.57 -4.28 -13.89 -5.82 -5.82 -5.81 -5.34 -0.014 -0.628 -3.1 -2.16 -2.84 -1.26 -1.65 -1.7
Interest Income 7.52 20.2 5.57 2.23 0 0 0 0 0 0 0 0 0 0 0 0 0.037 0.766 1.14 0.565
Interest Expense 0.021 3.32 4.57 4.33 3.82 3.57 4.28 13.89 5.82 5.82 5.81 5.34 0.014 0.628 3.1 2.16 2.88 2.03 2.79 2.26
Equity & Other Income/(Expense) -3.71 20.04 1.39 -74.62 7.62 0.507 -10.59 0.637 0.385 -1.17 1.17 -0.525 2.28 -0.189 -0.637 -0.088 1.7 1.16 -0.17 -0.194
Income Before Tax -111.2 -138.3 -74.2 -192.9 -63.66 -54.1 -66.7 -61.42 -63.8 -80.18 -54.79 -57.7 -15.69 -18.89 -22.3 -16.82 -19.18 -29.65 -25.35 -23.55
Income Tax Expense -1.7 0.573 0.452 -2.83 -4.42 -1.08 -1.92 -2.41 -3.26 -4.19 -1.48 -4.88 0.137 0.136 0.166 0.083 -0.05 -0.147 0.105 0.194
Income Attributable to Non-Controlling Interest 18.79 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -0.194
Net Income -128.3 -138.9 -74.66 -190.1 -59.24 -53.02 -64.79 -59.01 -60.53 -75.98 -53.31 -52.83 -15.82 -19.02 -22.47 -16.9 -19.13 -29.5 -25.45 -23.55
Depreciation and Amortization 13.71 16.86 15.18 15.03 15.57 15.92 15.8 16.5 18.3 17.94 16.11 4.06 2.55 1.48 1.06 1.5 1.94 1.97 2.14 1.46
EBITDA -101.2 -158.4 -61.42 -101.2 -51.89 -35.11 -36.03 -31.66 -40.06 -55.25 -34.04 -47.77 -15.4 -16.59 -17.5 -13.07 -16.1 -27.58 -21.39 -20.2
Earnings Per Share (EPS) -0.341 -0.52 -0.94 -2.43 -0.78 -0.74 -0.97 -1.49 -1.84 -2.62 -1.86 -1.9 -0.62 -0.86 -1.26 -0.89 -11.02 -17.85 -13.47 -12.46
Diluted Earnings Per Share -0.341 -0.52 -0.94 -2.43 -0.78 -0.74 -0.97 -1.49 -1.84 -2.62 -1.86 -1.9 -0.62 -0.86 -1.26 -0.89 -11.02 -17.85 -13.47 -12.46
Weighted Average Shares Outstanding 382.6 352.7 79.16 78.31 75.79 72.04 66.78 39.65 32.98 29.01 28.71 27.77 25.48 22.14 17.85 18.98 1.74 1.65 1.89 1.89
Diluted Weighted Average Shares Outstanding 382.6 352.7 79.16 78.31 75.79 72.04 66.78 39.65 32.98 29.01 28.71 27.77 25.48 22.14 17.85 18.98 1.74 1.65 1.89 1.89
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us
Want to become our sponsor?
Check out our Affiliate Program